Identification of a Novel SSTR3 Full Agonist for the Treatment of Nonfunctioning Pituitary Adenomas.
Saved in:
| Title: | Identification of a Novel SSTR3 Full Agonist for the Treatment of Nonfunctioning Pituitary Adenomas. |
|---|---|
| Authors: | Modena D; Preclinical R&D, Italfarmaco Group, 20092 Cinisello Balsamo, Milan, Italy., Moras ML; Preclinical R&D, Italfarmaco Group, 20092 Cinisello Balsamo, Milan, Italy., Sandrone G; Preclinical R&D, Italfarmaco Group, 20092 Cinisello Balsamo, Milan, Italy., Stevenazzi A; Preclinical R&D, Italfarmaco Group, 20092 Cinisello Balsamo, Milan, Italy., Vergani B; Preclinical R&D, Italfarmaco Group, 20092 Cinisello Balsamo, Milan, Italy., Dasgupta P; Institute of Pharmacology and Toxicology, Universitätsklinikum Jena, Friedrich-Schiller-Universität, 07747 Jena, Germany., Kliever A; Institute of Pharmacology and Toxicology, Universitätsklinikum Jena, Friedrich-Schiller-Universität, 07747 Jena, Germany., Gulde S; Institute for Diabetes and Cancer, Helmholtz Zentrum München, 85764 Neuherberg, Germany.; Joint Heidelberg-IDC Translational Diabetes Program, Heidelberg University Hospital, 69120 Heidelberg, Germany., Marangelo A; Institute for Diabetes and Cancer, Helmholtz Zentrum München, 85764 Neuherberg, Germany.; Joint Heidelberg-IDC Translational Diabetes Program, Heidelberg University Hospital, 69120 Heidelberg, Germany.; Department of Biology and Biotechnology 'L. Spallanzani', University of Pavia, 27100 Pavia, Italy., Schillmaier M; Department of Nuclear Medicine, Klinikum Rechts der Isar, School of Medicine, Technical University of Munich, 80333 Munich, Germany.; Department of Diagnostic and Interventional Radiology, Klinikum Rechts der Isar, School of Medicine, Technical University of Munich, 80333 Munich, Germany., Luque RM; Maimonides Biomedical Research Institute of Cordoba (IMIBIC), 14004 Cordoba, Spain.; Department of Cell Biology, Physiology and Immunology, University of Cordoba, 14004 Cordoba, Spain.; Reina Sofia University Hospital (HURS), 14004 Cordoba, Spain.; CIBER Physiopathology of Obesity and Nutrition (CIBERobn), 14004 Cordoba, Spain., Bäuerle S; Department of Mathematics, Technical University Munich, 85748 Garching, Germany., Pellegata NS; Institute for Diabetes and Cancer, Helmholtz Zentrum München, 85764 Neuherberg, Germany.; Joint Heidelberg-IDC Translational Diabetes Program, Heidelberg University Hospital, 69120 Heidelberg, Germany.; Department of Biology and Biotechnology 'L. Spallanzani', University of Pavia, 27100 Pavia, Italy., Schulz S; Institute of Pharmacology and Toxicology, Universitätsklinikum Jena, Friedrich-Schiller-Universität, 07747 Jena, Germany., Steinkühler C; Preclinical R&D, Italfarmaco Group, 20092 Cinisello Balsamo, Milan, Italy. |
| Source: | Cancers [Cancers (Basel)] 2023 Jun 30; Vol. 15 (13). Date of Electronic Publication: 2023 Jun 30. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: MDPI Country of Publication: Switzerland NLM ID: 101526829 Publication Model: Electronic Cited Medium: Print ISSN: 2072-6694 (Print) Linking ISSN: 20726694 NLM ISO Abbreviation: Cancers (Basel) Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2072-6694 |
|---|---|
| DOI: | 10.3390/cancers15133453 |
